Download the appMore options
PisaczekSearch
文AEN
Vitamins and minerals

Swelling and inflammation? Pineapple contains bromelain, but stomach acid may inactivate it!

Sources: 11 · Article: 17 044 characters ↓

What do Natural Therapy Specialists write?

Henryk Różański

Bromelain is a protein-digesting enzyme found in pineapple fruit.

„Bromelain is a proteolytic enzyme (protease) found in pineapple fruit—Ananas comosus. This enzyme hydrolyzes proteins and amides. Bromelain has a molecular weight of 28,000 daltons. Its activity is expressed in casein-digesting units (CDU), gelatin-digesting units (GDU), and milk-clotting units (MCU).”Bromelina (bromelain) jest proteolitycznym enzymem (proteaza) występującym w owocach ananasu – Ananas comosus. Enzym ten hydrolizuje białka i amidy. Masa cząsteczkowa bromeliny 28000 daltonów. Aktywność bromeliny jest wyrażana w jednostkach trawienia kazeiny CDU, w jednostkach trawienia żelatyny GDU, w jednostkach ścinania mleka MCU.
Henryk Różański

Bromelain is believed to have anti-inflammatory effects, attributed to its influence on plasmin, plasminogen, and kinins.

„Bromelain activates the production of plasmin and plasminogen and reduces kinin levels (it inhibits the conversion of kininogen into kinins). This is how bromelain’s anti-inflammatory effect is explained. Bromelain works at a pH of 3 to 10. It becomes active in the small intestine, so it is best taken in enteric-coated capsules.”Bromelina aktywuje produkcję plazminy i plazminogenu, a redukuje poziom kinin (hamuje transformację kininogenu do kininy). Tym tłumaczony jest efekt przeciwzapalny, jaki przynosi bromelina. Bromelina działa przy pH od 3 do 10. Uaktywnia się w jelicie cienkim, dlatego najlepiej zażywać ją w formie kapsułek dojelitowych.
Henryk Różański

Bromelain becomes active in the small intestine, while hydrochloric acid and stomach enzymes may inactivate it.

„It becomes active in the small intestine, so it is best taken in enteric-coated capsules. Hydrochloric acid and stomach enzymes can inactivate bromelain. Oral products containing 100 to 500 mg of bromelain per tablet or capsule are available.”Uaktywnia się w jelicie cienkim, dlatego najlepiej zażywać ją w formie kapsułek dojelitowych. Kwas solny i enzymy żołądkowe mogą inaktywować (unieczynniać) bromelinę. W obrocie są preparaty doustne zawierające w 1 tabletce lub kapsułce od 100 do 500 mg bromeliny.
Henryk Różański

Henryk Różański describes the use of bromelain in products that aid digestion and in treating abscesses, blood clots, swelling, ulcers, and inflammatory skin conditions.

„In medicine, bromelain is used in products that aid the digestion of dietary proteins, administered by injection to treat abscesses, blood clots, and swelling, and applied externally to treat ulcers, abscesses, and inflammatory skin conditions. Its therapeutic effects come from digesting cell membranes, which helps swelling and inflammation subside more quickly, helps antibiotics reach infected areas, and hydrolyzes blood clots.”W medycynie bromelina znalazła zastosowanie w produkcji preparatów wspomagających trawienie białek pokarmowych, pozajelitowo do leczenia ropni, zakrzepów, obrzęków, zewnętrznie do leczenia owrzodzeń, ropni i stanów zapalnych skóry. Właściwości lecznicze polegają na trawieniu błon komórkowych, przez co szybciej ustępują obrzęki i stany zapalne, ułatwianiu przenikania antybiotyków do zainfekowanego miejsca, hydrolizie zakrzepów.
Henryk Różański

Cosmetics containing bromelain act on the surface and do not penetrate into the deeper layers of the skin.

„Cosmetics containing bromelain are not absorbed through the skin and act on its surface, so they affect the degree of keratinization of the skin and hair follicles, as well as the condition of the epidermis. However, enzymes cannot penetrate into the deeper layers of the skin and modify collagen fibers there.”Kosmetyki zawierające bromelinę nie sa absorbowane przez skórę i działają powierzchniowo, zatem wpływaja na stopień rogowacenia skóry, mieszków włosowych, stan naskórka. Niemozliwe jest jednak, aby enzymy przenikały do głębokich partii skóry i modyfikowały w nich włókna kolagenowe.
Henryk Różański

Oral bromelain is not specifically transported from the digestive tract to a selected area of the skin.

„The body cannot transport bromelain from the digestive tract to a specific area of the skin in a targeted and controlled way. This is not possible, so claims on supplements such as “oral bromelain will remove cellulite” are nonsense. The same is true of shaping muscles with bromelain.”Organizm nie ma możliwości docelowego i kontrolowanego transportu bromeliny z przewodu pokarmowego do określonego obszaru skóry. To nie jest możliwe, zatem reklamy na suplementach typu: „bromelina zażywana doustnie usunie cellulitis” jest bzdurą. Podobnie zresztą jest z kształtowaniem mięśni za pomoca bromeliny.

What does scientific research from PubMed · Europe PMC say?

We selected 10 studies with the best, positive results. This is a selection, not a full review of all research.

Total number of studies on this topic in PubMed: 168.

Aim of the study: The inflammatory process is a response mechanism to any stressor. New treatment options derived mainly from natural products such as bromelain have been used to reduce the significant side effects of available anti-inflammatory drugs. Bromelain is an enzyme complex derived from Ananas comosus, known for its anti-inflammatory potential and good tolerability.

Results: A total of 1,375 studies were retrieved, of which 269 were duplicates. Seven (7) randomized controlled trials were eligible for the systematic review. In most studies, supplementation with bromelain, alone or as part of combination therapy, reduced inflammatory markers. Among studies where bromelain was used in combination with other treatments, two reported a reduction in inflammatory markers; two studies also showed a reduction when bromelain was evaluated on its own. Doses in studies using bromelain in combination ranged from 99.9 to 1,200 mg/day, and supplementation lasted from 3 to 16 weeks. The inflammatory markers measured were IL-12, PGE-2, COX-2, IL-6, IL-8, TNF-α, IL-1β, IL-10, CRP, NFγ B1, PPAR-α, TNF, TRAF, MCP-1, and adiponectin. In studies using bromelain alone, doses ranged from 200 to 1,050 mg/day, and supplementation lasted from 1 to 16 weeks.

Money for the studyuniversity or foundation · Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado do Piauí, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyreview of many studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Inflammation is a complex and necessary mechanism by which an organ responds to biological, chemical, and/or physical stimuli. In recent years, research into natural compounds with therapeutic effects for treating various diseases has increased.

Results: Among these compounds, bromelain stands out as a cysteine protease isolated from the stem of Ananas comosus (pineapple). This review aimed to evaluate bromelain’s anti-inflammatory activity and its effects on inflammatory mediators through a systematic review of in vitro studies using different cell lines. The search was conducted in the PubMed, Science Direct, Scopus, Cochrane Library, and Web of Science databases. Bromelain reduced IL-1β, IL-6, and TNF-α secretion in immune cells that had already been stimulated to overproduce pro-inflammatory cytokines. It modulated the inflammatory response by reducing prostaglandins and activating a cascade of reactions that trigger neutrophils and macrophages, as well as accelerating the healing process.

Money for the studyuniversity or foundation · Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brazil (CAPES) – Finance Code 001
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyreview of many studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: The aim of this systematic review was to determine whether bromelain is an effective drug for controlling pain and inflammation associated with third molar surgery. Randomized, controlled clinical trials on the subject were identified through a systematic search of the literature using the PubMed/MEDLINE, Scopus, and Cochrane Library databases.

Results: A meta-analysis of pain and trismus outcomes was performed using the inverse variance method for continuous outcomes, considering the mean difference (MD) and corresponding 95% confidence interval (CI). A total of 186 articles were initially retrieved from the databases. After the different stages of the selection process, five articles reporting data for a total of 252 patients remained and were included in the review. Bromelain proved effective at controlling postoperative pain 48–72 hours after surgery (P=0.03; MD -0.89, 95% CI -1.70 to -0.09), but did not have a significant effect compared with the control group on swelling or trismus.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studycombined analysis of many studies (meta-analysis)

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Traumatic brain injury (TBI) is the leading cause of death from injury. Many studies have shown that cytokines, chemokines, and oxidative stress play a crucial role in the pathophysiology of TBI.

Results: Bromelain supplementation significantly improved IL-6 levels and APACHE, SOFA, and NUTRIC scores, and reduced 60-day mortality in patients with traumatic brain injury. However, its effects on CRP, MDA, and TAC levels were not statistically significant. These findings suggest that bromelain may be a promising add-on treatment to reduce inflammation and improve clinical outcomes in critically ill TBI patients. Further studies with larger sample sizes and longer follow-up periods are needed to confirm these results.

Money for the studynot stated
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studyclinical study in people

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Diabetes mellitus (DM) is a chronic metabolic disorder that affects millions of people worldwide. Growing evidence suggests that hyperglycemia in DM causes a pre-aging and pro-inflammatory condition known as inflammaging, which increases susceptibility to periodontitis. Bromelain has been shown to have anti-inflammatory and anti-aging properties in various tissues, but its effects on diabetic periodontitis remain unclear.

Results: Bromelain concentrations ranging from 2.5 to 20 g/mL had no adverse effect on HGF cell proliferation. Bromelain improved wound healing in HGFs stimulated with AGEs. It also suppressed the production of the pro-inflammatory cytokines IL-6 and IL-8 in HGFs triggered by AGEs. Bromelain treatment also inhibited cellular senescence and p16 expression in AGEs-stimulated HGFs. Western blot analysis showed that bromelain inhibited the increase in p-ERK, p-p38, and p65 induced by AGEs in HGFs. These data suggest that excessive AGEs in the gingiva may lead to the accumulation of pro-inflammatory cytokines and marked cellular senescence. Bromelain may help enhance wound healing by reducing inflammaging through the downregulation of NF-κB and MAPK/ERK signaling pathways in people with DM and periodontal disease.

Money for the studyuniversity or foundation · Chung Shan Medical University Hospital
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studylaboratory study (on cells)

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Background and Objectives: Bromelain is a mixture of proteases obtained from pineapple fruit or stems. Although its biological mechanism of action is not fully understood, bromelain is known to have anticancer, anti-inflammatory, and immunomodulatory effects.

Results: Bromelain also promoted ALP activity and the formation of mineralized nodules. Conclusions: Bromelain inhibits the expression of inflammatory cytokines in LPS-stimulated hDPCs. Its inhibitory effect on inflammatory mediators is related to reduced NF-κB activity and the MAPK pathway. Therefore, bromelain may have potential for use in regenerative endodontics, including vital pulp therapy.

Money for the studycompany together with others · National Research Foundation of Korea, Chonnam National University
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studylaboratory study (on cells)

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: The aim of this study was to investigate the molecular, biochemical, and histopathological effects of bromelain, which has antioxidant and anti-inflammatory properties, against cisplatin-induced ocular toxicity. The groups were designed as follows: (1) Control, (2) Cisplatin (7 mg/kg, intraperitoneally), (3) Cisplatin + Bromelain (50 mg/kg, orally for 14 consecutive days), and (4) Cisplatin + Bromelain (100 mg/kg, orally for 14 consecutive days).

Results: The mRNA expression of NF-κB and Caspase-3 was also assessed. Eye tissue sections were also examined histopathologically. Bromelain showed a dose-dependent protective effect against cisplatin-induced toxicity by regulating oxidative stress, inflammation, and tissue damage. Our results suggest that bromelain may be a potential add-on treatment to protect the eye from cisplatin-induced toxicity.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyanimal study

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: This study aimed to investigate how bromelain protects glial cells from damage induced by pentylenetetrazole (PTZ), focusing on its anti-inflammatory effects. C6 glioma cells were treated with PTZ, bromelain, or a combination of PTZ and bromelain.

Results: On the other hand, bromelain at 50 µg/mL reduced inflammation, as shown by lower levels of NO, iNOS, and COX2 (p < 0.001). In-silico predictions suggest that bromelain can effectively target iNOS and COX2, key inflammatory proteins. These findings indicate that bromelain protects glial cells through its anti-inflammatory effects. However, further research is needed to fully understand the underlying mechanisms.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyanimal study

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: The objective of this study is to evaluate the effects of bromelain on serum endocannabinoid levels and oxidative stress markers in a rat model of surgically induced endometriosis.

Results: Induction of endometriosis significantly reduced serum 2-arachidonoylglycerol, anandamide, superoxide dismutase, and glutathione levels, while increasing malondialdehyde concentrations compared with the Sham group (p<0.05). Bromelain treatment significantly improved most endocannabinoid and oxidative stress markers compared with the untreated endometriosis group (p<0.05). Bromelain eased endocannabinoid deficiency and oxidative stress in experimental endometriosis. These findings suggest that bromelain may be a promising non-hormonal treatment candidate targeting interconnected inflammatory and redox pathways in endometriosis.

Money for the studynot stated
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studyanimal study
Participants24

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Inflammation and increased oxidative stress in testicular tissue are documented side effects of testicular torsion. This study investigated the preventive role of bromelain (Bro) against testicular torsion-induced ischemia/reperfusion (I/R) injury.

Results: Sperm morphology, motility, and concentration improved notably in the bromelain-treated group, according to spermatological examination. Histological evaluations showed less tissue damage in testicular samples treated with bromelain than in the untreated I+R group. These findings suggest that Bro has anti-inflammatory, anti-apoptotic, and antioxidant properties. It effectively reduces oxidative stress and inflammation by modulating the PI3K/Akt/mTOR and NRF-2/HO-1 pathways, thereby minimizing I/R injury.

Money for the studygovernment, public institutions · National Science and Technology Council, Taiwan
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studyanimal study

“Not stated” does not mean nobody paid — the database does not always record it.

Sources (11)

Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.